Cancer treatment method

• US 6,199,555 B1
• Filed: 05/01/1998
• Issued: 03/13/2001
• Est. Priority Date: 05/01/1998
• Status: Expired due to Fees

• Current Assignee: Peter J. Wilk, Sudol, R. Neil
• Original Assignee: Peter J. Wilk, Sudol, R. Neil
• Inventors: Sudol, R. Neil, Wilk, Peter J.
• Primary Examiner(s): Nguyen, Dinh X.
• Application Number:
  US09/071,430
• Time in Patent Office: 1,047 Days
• Field of Search: 128/898
• US Class Current: 128/898
• CPC Class Codes: A61B 18/04 by heating by applying electromagnetic radiation A61B18/18; hyperthermia using electric or magnetic fields, radiation or ultrasound A61N
• CPC Class Codes: A61B 18/08 by means of electrically-heated probes
• CPC Class Codes: A61B 2018/046 in liquid form

Abstract

In a method for treating cancer, a tube is inserted into a patient, so that a distal end of the tube is disposed proximately to a tumor. A sclerosing agent such as a concentrated sugar solution is then fed through the tube into the patient and into the tumor. The tube can take the form of a catheter which is introduced into the patient through the patient'"'"'s vascular system.

Claims

1. A method for treating cancer, comprising:

inserting a tube into a patient, so that a distal end of said tube is disposed proximately to a tumor; and

feeding a sclerosing agent including a sugar through said tube into the patient and into the tumor.

2. The method defined in claim 1 wherein said tube is a catheter, the inserting of said catheter including the step of guiding said catheter through a vascular system of the patient so that a distal tip of said catheter is disposed proximately to the tumor in an artery supplying the tumor.

3. The method defined in claim 2 wherein said sugar is introduced into said catheter in a form for inhibiting adherence of sugar to an inner surface of said catheter.

4. The method defined in claim 3 wherein said sugar is introduced into said catheter in the form of pellets with time release outer coatings.

5. The method defined in claim 4 wherein said sugar is introduced into said catheter in the form of pellets which are hard throughout.

6. The method defined in claim 3 wherein said sugar is introduced into said catheter in a form which dissolves at a predetermined rate in body fluids.

7. The method defined in claim 6 wherein said catheter is provided with means for heating at least a distal end portion of said catheter, thereby facilitating dissolving of the sugar in blood fluids.

8. The method defined in claim 2 wherein said catheter is provided with means for heating said catheter, further comprising the step of operating said means for heating during feeding of said sclerosing agent through said catheter, thereby inhibiting adhesion of sugar to an inner surface or lumen of said catheter.

9. The method defined in claim 8 wherein said means for heating includes a wire obturator disposed inside said catheter.

10. The method defined in claim 2, further comprising the steps of inserting a wire obturator periodically into said catheter and conducting electrical current through said obturator to heat said obturator and clear sugar deposits from a lumen of said catheter.

11. The method defined in claim 2, further comprising inflating a balloon at a distal tip of said catheter after disposition of said distal tip proximately to said tumor and prior to feeding of said sclerosing agent through said catheter.

12. The method defined in claim 1 wherein the inserting of said tube includes inserting said tube through overlying organs and directly into the tumor.

13. The method defined in claim 12 wherein said sugar is introduced into said tube in a form for inhibiting adherence of sugar to an inner surface of said tube.

14. The method defined in claim 13 wherein said sugar is introduced into said tube in the form of pellets with hardened outer surfaces.

15. The method defined in claim 14 wherein said sugar is introduced into said tube in the form of pellets which are hard throughout.

16. The method defined in claim 12 wherein said sugar is introduced into said tube in a form which dissolves at a predetermined rate in body fluids.

17. The method defined in claim 15 wherein said catheter is provided with means for heating at least a distal end portion of said catheter, thereby facilitating dissolving of the sugar in blood fluids.

18. The method defined in claim 12 wherein said tube is provided with means for heating at least a distal end portion of said tube, thereby inhibiting adhesion of sugar to an inner surface or lumen of said tube.

19. The method defined in claim 1, further comprising the step of delivering a vasoconstrictive agent to a venous system for said tumor.

20. The method defined in claim 19 wherein said vasoconstrictive agent is delivered to the venous system of the tumor substantially simultaneously with the feeding of said sclerosing agent into the tumor.

21. The method defined in claim 20 wherein said vasoconstrictive agent is taken from the group consisting essentially of caffeine and nicotine.

22. The method defined in claim 1 wherein said sclerosing agent is fed into the tumor at an elevated temperature.

23. The method defined in claim 1 wherein the tumor has a substantially dedicated venous system, the feeding of said sclerosing agent includes the step of sclerosing all of the veins of the tumor'"'"'s venous system.